🔗 Permalink

Inventor profile of:

Per Sauerberg

City:

Farum

Country:

Denmark

Published Applications:

57

Last publication date:

2026-03-26

Top Assignees for applications by Per Sauerberg

The entities that hold a legal rights for patent applications filed by inventor Sauerberg Per:

Novo Nordisk A/S 31 Bagsvaerd, Denmark
HIGH POINT PHARMACEUTICALS, LLC 10 High Point, NC United States
VTV THERAPEUTICS LLC 5 High Point, NC United States
Novo Novdisk A/S 1 Bagsvaerd, Denmark

Recent patent applications by Sauerberg Per

Per Sauerberg from Farum, DK has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-26

US20260083678A1

Human necessities

Oral Dosing of GLP-1 Compounds

#2 | 2025-08-21

US20250262159A1

Human necessities

Oral Dosing of GLP-1 Compounds

#3 | 2025-07-03

US20250213485A1

Human necessities

Oral Dosing of GLP-1 Compounds

#4 | 2025-04-17

US20250122226A1

Chemistry; metallurgy

GLUCOSE-SENSITIVE ALBUMIN-BINDING DERIVATIVES

#5 | 2024-08-22

US20240277817A1

Human necessities

SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID

#6 | 2023-10-19

US20230331745A1

Chemistry; metallurgy

Glucose-sensitive albumin-binding derivatives

#7 | 2023-09-28

US20230302092A1

Human necessities

SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID

#8 | 2022-10-06

US20220313786A1

Human necessities

SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID

#9 | 2022-06-16

US20220184184A1

Human necessities

GLUCOSE SENSITIVE INSULIN DERIVATIVES

#10 | 2022-03-17

US20220081451A1

Chemistry; metallurgy

Glucose-sensitive albumin-binding derivatives

#11 | 2022-03-03

US20220062184A1

Human necessities

Pharmaceutical Composition for Oral GLP-1 Administration Comprising a Tablet Core and Immediate Release Coating

#12 | 2022-02-17

US20220047708A1

Human necessities

Glucose sensitive insulins and uses thereof

#13 | 2021-09-09

US20210275458A1

Human necessities

TABLET FORMULATION COMPRISING A GLP-1 PEPTIDE AND A DELIVERY AGENT

#14 | 2021-06-24

US20210188758A1

Chemistry; metallurgy

Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

#15 | 2021-06-17

US20210177944A1

Human necessities

Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid

#16 | 2020-10-15

US20200325160A1

Chemistry; metallurgy

Glucose-sensitive albumin-binding derivatives

#17 | 2020-07-09

US20200215073A1

Human necessities

Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

#18 | 2019-07-18

US20190216739A1

Human necessities

Oral dosing of GLP-1 compounds

#19 | 2018-12-20

US20180360918A1

Human necessities

Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl) amino) caprylic acid

#20 | 2018-09-20

US20180263915A1

Human necessities

Pharmaceutical Composition for Oral GLP-1 Administration Comprising a Tablet Core and Immediate Release Coating

#21 | 2018-08-23

US20180235888A1

Human necessities

Tablet formulation comprising a GLP-1 peptide and a delivery agent

#22 | 2018-03-15

US20180071304A1

Human necessities

Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

#23 | 2017-11-09

US20170320927A1

Chemistry; metallurgy

GLP-1 derivatives and uses thereof

#24 | 2017-11-02

US20170312225A1

Human necessities

Oral dosing of GLP-1 compounds

#25 | 2017-08-03

US20170216303A1

Human necessities

Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

#26 | 2017-01-12

US20170007707A1

Human necessities

Derivatives of GLP-1 like peptides, and uses thereof

#27 | 2016-07-14

US20160200791A1

Chemistry; metallurgy

GLP-1 derivatives, and uses thereof

#28 | 2016-06-02

US20160151462A1

Human necessities

Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid

#29 | 2016-05-26

US20160143998A1

Human necessities

GLP-1 derivatives and uses thereof

#30 | 2016-03-10

US20160067184A1

Human necessities

Oral Dosing of GLP-1 Compounds

#31 | 2015-06-04

US20150150811A1

Human necessities

Tablet formulation comprising semaglutide and a delivery agent

#32 | 2015-01-08

US20150011462A1

Human necessities

Derivatives of GLP-1 like peptides, and uses thereof

#33 | 2014-06-26

US20140179899A1

Chemistry; metallurgy

Double-acylated GLP-1 derivatives

#34 | 2014-01-23

US20140024645A1

Chemistry; metallurgy

Phenoxy acetic acids and phenyl propionic acids as PPARδ agonists

#35 | 2013-12-26

US20130345134A1

Human necessities

Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid

#36 | 2013-10-31

US20130288960A1

Chemistry; metallurgy

Double-acylated GLP-1 derivatives

#37 | 2013-04-25

US20130102610A1

Chemistry; metallurgy

Phenoxy acetic acids as PPAR delta activators

#38 | 2012-02-23

US20120046350A1

Chemistry; metallurgy

NOVEL COMPOUNDS, THEIR PREPARATION AND USE

#39 | 2011-10-06

US20110245244A1

Chemistry; metallurgy

Phenyl propionic acids as PPAR delta activators

#40 | 2011-07-07

US20110166321A1

Chemistry; metallurgy

Double-acylated GLP-1 derivatives

#41 | 2011-02-17

US20110039841A1

Chemistry; metallurgy

Novel compounds, their preparation and use

#42 | 2010-10-19

US10734368

Dimeric dicarboxylic acid derivatives, their preparation and use

#43 | 2010-08-19

US20100210653A1

Chemistry; metallurgy

Novel Compounds, Their Preparations and Use

#44 | 2009-08-20

US20090209588A1

Chemistry; metallurgy

Compounds, their preparation and use

#45 | 2009-04-09

US20090093484A1

Chemistry; metallurgy

Compounds, their preparation and use

#46 | 2009-02-19

US20090048257A1

Chemistry; metallurgy

Compounds that modulate PPAR activity, their preparation and use

#47 | 2008-05-15

US20080114036A1

Chemistry; metallurgy

Novel Compounds, Their Preparations And Use

#48 | 2007-05-22

US10272613

Compounds, their preparation and use

#49 | 2007-04-10

US10442284

Combination therapy using a dual PPAR-α/PPAR-γ activator and a GLP-1 derivative for the treatment of metabolic syndrome and related diseases and disorders

#50 | 2006-12-21

US20060287393A1

Chemistry; metallurgy

Compounds, their preparation and use

#51 | 2006-08-15

US10654699

Compounds, their preparation and use

#52 | 2006-06-27

US10217595

Compounds, their preparation and use

#53 | 2005-12-06

US9551740

Compounds, their preparation and use

#54 | 2005-04-14

US20050080115A1

Chemistry; metallurgy

Novel compounds, their preparation and use

#55 | 2005-03-31

US20050070583A1

Chemistry; metallurgy

Peroxisome proliferator activated receptor-active arylene acetic acid derivatives

#56 | 2005-03-22

US10201456

Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives

#57 | 2005-03-15

US10370856

Compounds, their preparation and use

InventorID:

211327 ⎘